IntegraGen S.A.
ALINT.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.30 | 0.03 | -0.12 |
| FCF Yield | -19.64% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -1.43 | -1.42 | -29.89 | 30.96 |
| Quality | ||||
| ROIC | -191.81% | -6.88% | -11.28% | 8.32% |
| Gross Margin | -56.99% | 55.29% | -10.53% | 41.60% |
| Cash Conversion Ratio | 0.46 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -0.72% | 7.17% | 13.02% | 19.11% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.89 | 0.70 | -0.06 | -4.24 |
| Interest Coverage | -1,008.93 | -184.65 | -151.40 | 70.65 |
| Efficiency | ||||
| Inventory Turnover | 14.95 | 9.08 | 15.12 | 12.16 |
| Cash Conversion Cycle | 26.06 | 35.02 | 57.82 | 35.77 |